alpha emitting radionuclides considerable targeted radioimmunotherapy generator supplied 213bi emitting NUMBER mev alpha particles NUMBER min conjugated monoclonal antibody targeted therapy leukemia clinical trial clinical dose preparation pharmaceutical formulation pair skilled radiochemists took NUMBER min corresponds overall decay loss NUMBER initial 213bi activity eluted generator order allow widespread practical clinical use targeted 213bi alpha particle therapy developed new procedure simpler rapid adaptable hospital pharmacy new NUMBER min process includes tandem elution labeling anion exchange column purification method reproducibly used half life hum195 chx dtpa